Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

Post by retiredcfon Jun 04, 2019 2:21pm
51 Views
Post# 29797729

SmallCapPower Article

SmallCapPower Article

The U.S. cannabis stocks we’ve found have a presence in Illinois and could benefit from the recent legalization of recreational cannabis in that state

 

SmallCapPower | June 4, 2019: On May 31, 2019, after a contentious debate in Springfield, Illinois lawmakers finally approved recreational marijuana legalization. Illinois is now the 11th U.S. state to legalize and regulate adult-use cannabis, and legal use will start in January 1, 2020. With a population of close to 13 million, the Dekkert Hewitt group estimates the Illinois medical and recreational opportunity could potentially represent over US$3B in sales. Today we have discovered four U.S. cannabis stocks that have a presence within Illinois and could benefit from recreational legalization in that state.

*Share prices as at close Friday, May 31, 2019, data obtained from S&P Capital IQ

Cresco Labs Inc. (CSE:CL) – $15.27
Cannabis

Based in Chicago, Cresco Labs is a vertically-integrated cannabis cultivator, manufacturer, and retailer. CL offers its cannabis products in flower, vape pens, and various forms of extracts under the Cresco and Reserve brands. It also sells noncombustible products, which include tinctures, capsules, salves, and transdermal patches under the Remedi brand. Along with Pennsylvania and Florida, Illinois is one of Cresco’s primary sources of revenue. CL owns and operates the maximum five dispensaries allowed by state regulations and has a 27% share of the state’s wholesale market. The legalization would allow CL to obtain another five dispensary licenses, allowing Cresco to continue its growth in its home country.

  • Market Cap: $5.1B
  • YTD Return: 62.7%
  • 90 Day Average Trading Volume: 300,000

<< Previous
Bullboard Posts
Next >>